Chlormerodrin Hg 203 and Electrolyte Distribution in Murine Brain Tumors
- 1 November 1965
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 13 (5) , 525-532
- https://doi.org/10.1001/archneur.1965.00470050073008
Abstract
THE EMERGENCE of scintillation scanning of the brain for localization of brain tumors has been a major advance in neurological diagnosis. Moore,1 in 1948, was able to localize brain tumors by the use of radioactive iodine-labeled diiodofluorescein and a Geiger-Meuller tube. Since this time there have been major technological advances with the development of sensitive scintillation counters, automatic scanning equipment, and focusing collimators.2 The most commonly employed agent for brain tumor localization has been iodinated I 131 serum albumin,3 although other compounds have been employed. In 1959, Chlormerodrin Hg-203 was introduced as an agent for brain tumor localization by Blau and Bender,4 and numerous reports since have attested to its value in brain tumor localization.5-8 The mechanism of localization of brain tumors by scintillation scanning has received some attention in the literature but further information is needed to understand more fully the manner inThis publication has 8 references indexed in Scilit:
- Brain Scans in Diagnosis of Cerebrovascular DiseaseJAMA, 1965
- Scintiscanning in Space-occupying Lesions of the SkullThe British Journal of Radiology, 1965
- CEREBRAL CIRCULATION STUDIES DURING HYPOTENSIVE ANÆSTHESIA USING RADIOACTIVE XENONThe Lancet, 1963
- Mercury 203 Brain ScanningRadiology, 1963
- LOCALIZATION OF OCTOIODOFLUORESCEIN-I131 IN MOUSE BRAIN TUMORS1961
- EXPERIMENTAL BRAIN TUMORS IN RABBITS AND ASSOCIATED CEREBRAL EDEMA1961
- Electrolyte distribution in mammalian central nervous systemNeurology, 1961
- Binding of the Mercury of an Organic Mercurial Diuretic by Plasma Proteins.Experimental Biology and Medicine, 1950